Epigenomics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Noel Doheny

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure12.8yrs
CEO ownershipn/a
Management average tenure2yrs
Board average tenureno data

Recent management updates

Recent updates


CEO

Noel Doheny

12.8yrs

Tenure

Dr. Noel Thomas Doheny has been the Chief Executive Officer of Epigenomics Inc. at Epigenomics AG since May 2011. Dr. Doheny manages all US activities and global business development and partnership develo...


Leadership Team

NamePositionTenureCompensationOwnership
Jens Ravens
Executive VP of Finance & Member of Executive Board2yrs€220.04kno data
Hansjorg Plaggemars
Member of Executive Boardno datano datano data
Frederic Hilke
Investor Relations Officerno datano datano data
Noel Doheny
Chief Executive Officer of Epigenomics Inc.12.8yrsno datano data

2.0yrs

Average Tenure

Experienced Management: EPGN.F's management team is considered experienced (2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.